Contributing factors related to efficacy of the dipeptidyl peptidase-4 inhibitor sitagliptin in Japanese patients with type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 95, Issue 2, 2012, Pages

  Nomiyama, Takashi ^a   Akehi, Yuko ^a   Takenoshita, Hiromasa ^a   Nagaishi, Ryoko ^a   Terawaki, Yuichi ^a   Nagasako, Hisahiro ^a   Kudo, Tadachika ^b   Kodera, Takehiko ^b   Kobayashi, Kunihisa ^b   Urata, Hidenori ^b   Yanase, Toshihiko ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b Fukuoka University Chikushi Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; SITAGLIPTIN; SULFONYLUREA;

AGED; BLOOD PRESSURE REGULATION; DIABETES CONTROL; DIASTOLIC BLOOD PRESSURE; DIET THERAPY; DISEASE DURATION; DRUG EFFICACY; FEMALE; HUMAN; JAPAN; JAPANESE; LETTER; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ASIA; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIPEPTIDYL-PEPTIDASE IV INHIBITORS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PYRAZINES; TREATMENT OUTCOME; TRIAZOLES;

EID: 84856339225     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.08.016     Document Type: Letter

References (1)

1. Iwamoto Y., Taniguchi T., Nonaka K., Okamoto T., Okuyama K., Ferreira J., et al. Dose-ranging efficacy of sitagliptin, a dipeptidyl peptidase-4 inhibitor, in Japanese patients with type 2 diabetes mellitus. Endocr J 2010, 57:383-394.